Evofem Biosciences, Inc. (EVFM) › Weighted Average Diluted SharesEvofem Biosciences, Inc. (EVFM) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2020-12-31: 67.16M2021-12-31: 8.73M2022-12-31: 466.0K2023-12-31: 984.04M2024-12-31: 80.00M2025-12-31: 6.42B6.42B2020-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-316.42B+7926.9%2026-03-11From 2025-01-012024-12-3180.00M-91.9%2026-03-11From 2024-01-012023-12-31984.04M+211082.0%2025-03-24From 2023-01-012022-12-31466.0K-94.7%2024-03-27From 2022-01-012021-12-318.73M-87.0%2023-04-27From 2021-01-012020-12-3167.16M—2022-03-10From 2020-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)